Provenance du réseau au premier degré de Hergen Spits
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
62
| Subsidiary | Biotechnology | 62 |
University of Amsterdam
37
| College/University | Other Consumer Services | 37 |
DNAX Research, Inc.
5
| Subsidiary | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Hergen Spits via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| San Francisco State University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| The Genentech Foundation | Investment Trusts/Mutual Funds | Director of Finance/CFO Director of Finance/CFO Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Santa Clara University | College/University | Masters Business Admin Masters Business Admin | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Doctorate Degree Undergraduate Degree | |
| 23ANDME HOLDING CO. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
| University of California, Santa Cruz | College/University | Undergraduate Degree Corporate Officer/Principal | |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| Erasmus University Rotterdam | College/University | Masters Business Admin Doctorate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| Vanderbilt University | College/University | Graduate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree Undergraduate Degree | |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Delft University of Technology | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of San Francisco | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree Undergraduate Degree | |
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Chief Executive Officer General Counsel | |
| University of Massachusetts | College/University | Undergraduate Degree Doctorate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Doctorate Degree | |
| Sardona Therapeutics, Inc. | Director/Board Member Director/Board Member | ||
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 42 |
| Pays-Bas | 7 |
| Suisse | 2 |
| Belgique | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 20 |
| Commercial Services | 5 |
| Miscellaneous | 4 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 249 |
| Corporate Officer/Principal | 232 |
| Chief Tech/Sci/R&D Officer | 76 |
| Undergraduate Degree | 67 |
| Independent Dir/Board Member | 60 |
Relations les plus connectées
| Insiders | |
|---|---|
| Martijn Kleijwegt | 33 |
| Annemieke J. M. Roobeek | 29 |
| Sheila Gujrathi | 20 |
| Pamela Klein | 19 |
| David Schenkein | 18 |
| Carla M. C. Mahieu | 17 |
| Philip van den Berg | 17 |
| Henk ten Hove | 17 |
| Armen Shanafelt | 17 |
| Domenico Valerio | 15 |
| Eric J. Fischer | 15 |
| Michael Miller | 14 |
| Robert Schueren | 14 |
| Frank Lee | 13 |
| Martin Babler | 13 |
- Bourse
- Insiders
- Hergen Spits
- Connexions Sociétés
